Literature DB >> 1318397

Vesicular stomatitis virus matrix protein inhibits host cell-directed transcription of target genes in vivo.

B L Black1, D S Lyles.   

Abstract

Infection by vesicular stomatitis virus (VSV) results in a rapid inhibition of host cell transcription and translation. To determine whether the viral matrix (M) protein was involved in this inhibition of host cell gene expression, an M protein expression vector was cotransfected with a target gene vector, encoding the target gene, encoding chloramphenicol acetyltransferase (CAT). Expression of M protein caused a decrease in CAT activity in a gene dosage-dependent manner, and inhibition was apparent by 12 h posttransfection. The inhibitory effect of M protein was quite potent. The level of M protein required for a 10-fold inhibition of CAT activity was less than 1% of the level of M protein produced during the sixth hour of VSV infection. Northern (RNA) analysis of cotransfected cells showed that expression of M protein caused a reduction in the steady-state level of the vector-encoded mRNAs. Expression of both CAT and M mRNAs was reduced in cells cotransfected with a plasmid encoding M protein, indicating that expression of small amounts of M protein from plasmid DNA inhibits further expression of both M and CAT mRNAs. Nuclear runoff transcription analysis demonstrated that expression of M protein inhibited transcription of the target genes. This is the first report of a viral gene product which is capable of inhibiting transcription in vivo in the absence of any other viral component.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1318397      PMCID: PMC241208     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Inhibition of RNA synthesis in mouse myeloma cells infected with vesicular stomatitis virus.

Authors:  P K Weck; R R Wagner
Journal:  J Virol       Date:  1978-03       Impact factor: 5.103

2.  Mechansims of vesicular stomatitis virus-induced cytopathic effects. II. Inhibition of macromolecular synthesis induced by infectious and defective-interfering particles.

Authors:  B Baxt; R Bablanian
Journal:  Virology       Date:  1976-07-15       Impact factor: 3.616

3.  The requirement of protein synthesis for VSV inhibition of host cell RNA synthesis.

Authors:  M K Poirot; W M Schnitzlein; M E Reichmann
Journal:  Virology       Date:  1985-01-15       Impact factor: 3.616

4.  Inhibition of DNA-dependent transcription by the leader RNA of vesicular stomatitis virus: role of specific nucleotide sequences and cell protein binding.

Authors:  B W Grinnell; R R Wagner
Journal:  Mol Cell Biol       Date:  1985-10       Impact factor: 4.272

5.  Effect of U.v.-irradiated vesicular stomatitis virus on nucleic acid synthesis in chick embryo cells.

Authors:  Y Yaoi; H Mitsui; M Amano
Journal:  J Gen Virol       Date:  1970-09       Impact factor: 3.891

6.  Inhibition of host-cell protein and ribonucleic acid synthesis by Newcastle disease virus.

Authors:  D E Wilson
Journal:  J Virol       Date:  1968-01       Impact factor: 5.103

7.  Reovirus inhibition of cellular RNA and protein synthesis: role of the S4 gene.

Authors:  A H Sharpe; B N Fields
Journal:  Virology       Date:  1982-10-30       Impact factor: 3.616

8.  Instability of the viral M protein in BHK-21 cells persistently infected with Sendai virus.

Authors:  L Roux; F A Waldvogel
Journal:  Cell       Date:  1982-02       Impact factor: 41.582

9.  Vesicular stomatitis virus M protein in the nuclei of infected cells.

Authors:  D S Lyles; L Puddington; B J McCreedy
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

10.  Biased hypermutation and other genetic changes in defective measles viruses in human brain infections.

Authors:  R Cattaneo; A Schmid; D Eschle; K Baczko; V ter Meulen; M A Billeter
Journal:  Cell       Date:  1988-10-21       Impact factor: 41.582

View more
  75 in total

Review 1.  Cytopathogenesis and inhibition of host gene expression by RNA viruses.

Authors:  D S Lyles
Journal:  Microbiol Mol Biol Rev       Date:  2000-12       Impact factor: 11.056

2.  Infectious hematopoietic necrosis virus matrix protein inhibits host-directed gene expression and induces morphological changes of apoptosis in cell cultures.

Authors:  P P Chiou; C H Kim; P Ormonde; J A Leong
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

3.  Matrix protein and another viral component contribute to induction of apoptosis in cells infected with vesicular stomatitis virus.

Authors:  S A Kopecky; M C Willingham; D S Lyles
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

4.  Mutations in the PPPY motif of vesicular stomatitis virus matrix protein reduce virus budding by inhibiting a late step in virion release.

Authors:  H R Jayakar; K G Murti; M A Whitt
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

Review 5.  Transcriptional activation of alpha/beta interferon genes: interference by nonsegmented negative-strand RNA viruses.

Authors:  Karl-Klaus Conzelmann
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

6.  Immunogenicity of cytopathic and noncytopathic viral vectors.

Authors:  Gabriela Plesa; Philip M McKenna; Matthias J Schnell; Laurence C Eisenlohr
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

7.  Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses.

Authors:  Friedemann Weber; Valentina Wagner; Simon B Rasmussen; Rune Hartmann; Søren R Paludan
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

8.  Replication and amplification of novel vesicular stomatitis virus minigenomes encoding viral structural proteins.

Authors:  E A Stillman; J K Rose; M A Whitt
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

9.  Vesicular stomatitis virus matrix protein impairs CD1d-mediated antigen presentation through activation of the p38 MAPK pathway.

Authors:  Gourapura J Renukaradhya; Masood A Khan; Daniel Shaji; Randy R Brutkiewicz
Journal:  J Virol       Date:  2008-09-24       Impact factor: 5.103

10.  Protection against lethal vaccinia virus challenge by using an attenuated matrix protein mutant vesicular stomatitis virus vaccine vector expressing poxvirus antigens.

Authors:  Cassandra L Braxton; Shelby H Puckett; Steven B Mizel; Douglas S Lyles
Journal:  J Virol       Date:  2010-01-20       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.